Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience

被引:8
作者
Crepinsek, Klementina [1 ,2 ]
Marinsek, Gasper [1 ]
Kavcic, Marko [2 ,3 ]
Prelog, Tomaz [3 ]
Kitanovski, Lidija [3 ]
Jazbec, Janez [2 ,3 ]
Debeljak, Marusa [1 ,2 ]
机构
[1] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Clin Inst Special Lab Diagnost, Vrazov Trg 1, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[3] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Dept Oncol & Haematol, Ljubljana, Slovenia
关键词
B-acute lymphoblastic leukemia; IKZF1; deletions; IKZF1(plus); MLPA; pediatric; copy number variations (CNVs); IKZF1; DELETION; IKAROS GENE; PROGNOSTIC MARKER; POOR-PROGNOSIS; PRECURSOR; CHILDHOOD; CHILDREN; PAX5; STRATIFICATION; CLASSIFICATION;
D O I
10.2478/raon-2021-0050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background IKZF1 gene deletions have been identified as a poor prognostic factor in pediatric B-cell acute lymphoblastic leukemia (B-ALL), especially in the presence of co-occurring deletions (IKZF1(plus) profile). This study aimed to determine the frequency of IKZF1 deletions and deletions in other B-cell differentiation and cell cycle control genes, and their prognostic impact in Slovenian pediatric B-ALL patients. Patients and methods We studied a cohort of 99 patients diagnosed with B-ALL from January 2012 to December 2020 and treated according to the ALL IC-BFM 2009 protocol. Eighty-eight bone marrow or peripheral blood samples were analysed for copy number variations (CNVs) using the SALSA MLPA P335 ALL-IKZF1 probemix. Results At least one CNV was detected in more than 65% of analysed samples. The most frequently altered genes were PAX5 and CDKN2A/B (30.7%, 26.1%, and 25.0%, respectively). Deletions in IKZF1 were present in 18.2% of analysed samples and were associated with an inferior 5-year event-free survival (EFS; 54.8% vs. 85.9%, p = 0.016). The IKZF1(plus) profile was identified in 12.5% of the analysed samples, and these patients had an inferior 5-year EFS than those with deletions in IKZF1 only and those without deletions (50.8% vs. 75.0% vs. 85.9%, respectively, p = 0.049). Overall survival (OS) was also worse in patients with the IKZF1(plus) profile than those with deletions in IKZF1 only and those without deletions (5-year OS 76.2% vs. 100% vs. 93.0%, respectively). However, the difference between the groups was not statistically significant. Conclusions Our results are in concordance with the results obtained in larger cooperative clinical trials. Copy number variations analysis using the SALSA MLPA kit is a reliable tool for initial diagnostic approach in children with B-ALL, even in smaller institutions in low- and middle-income countries.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 50 条
  • [31] MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia
    Chaber, Radoslaw
    Gurgul, Artur
    Tabarkiewicz, Jacek
    Wrobel, Grazyna
    Szmatola, Tomasz
    Jasielczuk, Igor
    Haus, Olga
    Lejman, Monika
    Rybka, Blanka
    Ryczan-Krawczyk, Renata
    Jaskowiec, Anna
    Paszek, Sylwia
    Potocka, Natalia
    Arthur, Christopher J.
    Bal, Wioletta
    Lach, Kornelia
    Kowal, Aneta
    Zawlik, Izabela
    Latos-Grazynska, Elzbieta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (03): : 293 - 305
  • [32] What is the role for HSCT or immunotherapy in pediatric hypodiploid B-cell acute lymphoblastic leukemia?
    Talleur, Aimee C.
    Maude, Shannon L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 508 - 511
  • [33] PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia
    Bedics, Gabor
    Egyed, Balint
    Kotmayer, Lili
    Benard-Slagter, Anne
    de Groot, Karel
    Beko, Anna
    Hegyi, Lajos Laszlo
    Batai, Bence
    Krizsan, Szilvia
    Krivan, Gergely
    Erdelyi, Daniel J.
    Mueller, Judit
    Haltrich, Iren
    Kajtar, Bela
    Pajor, Laszlo
    Vojcek, Agnes
    Ottoffy, Gabor
    Ujfalusi, Aniko
    Szegedi, Istvan
    Tiszlavicz, Lilla Gyoergyi
    Bartyik, Katalin
    Csanadi, Krisztina
    Peter, Gyoergy
    Simon, Reka
    Hauser, Peter
    Kelemen, Agnes
    Sebestyen, Endre
    Jakab, Zsuzsanna
    Matolcsy, Andras
    Kiss, Csongor
    Kovacs, Gabor
    Savola, Suvi
    Bodor, Csaba
    Alpar, Donat
    BRITISH JOURNAL OF CANCER, 2023, 129 (03) : 455 - 465
  • [34] IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia
    Paolino, Jonathan
    Tsai, Harrison K.
    Harris, Marian H.
    Pikman, Yana
    BIOMEDICINES, 2024, 12 (01)
  • [35] Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments
    Huang, Fang-Liang
    Liao, En-Chih
    Li, Chia-Ling
    Yen, Chung-Yang
    Yu, Sheng-Jie
    ONCOLOGY LETTERS, 2020, 20 (01) : 448 - 454
  • [36] Blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Queudeville, Manon
    Schlegel, Patrick
    Heinz, Amadeus T.
    Lenz, Teresa
    Doering, Michaela
    Holzer, Ursula
    Hartmann, Ulrike
    Kreyenberg, Hermann
    von Stackelberg, Arend
    Schrappe, Martin
    Zugmaier, Gerhard
    Feuchtinger, Tobias
    Lang, Peter
    Handgretinger, Rupert
    Ebinger, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 473 - 483
  • [37] Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia
    Ofverholm, Ingegerd Ivanov
    Anh Nhi Tran
    Olsson, Linda
    Zachariadis, Vasilios
    Heyman, Mats
    Rudd, Eva
    Lundberg, Elisabeth Syk
    Nordenskjold, Magnus
    Johansson, Bertil
    Nordgren, Ann
    Barbany, Gisela
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2161 - 2170
  • [38] Cytologic Phenotypes of B-Cell Acute Lymphoblastic Leukemia-A Single Center Study
    Ramyar, Asghar
    Shafiei, Masoud
    Rezaei, Nima
    Asgarian-Omran, Hossein
    Esfahani, Shadi Abdar
    Moazzami, Kasra
    Sarafnejad, Abdolfattah
    Aghamohammadi, Asghar
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2009, 8 (02) : 99 - 106
  • [39] Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemia
    Ragnarsson, Charlotte
    Yang, Minjun
    Moura-Castro, Larissa Helena
    Aydin, Efe
    Gunnarsson, Rebeqa
    Olsson-Arvidsson, Linda
    Lilljebjorn, Henrik
    Fioretos, Thoas
    Duployez, Nicolas
    Zaliova, Marketa
    Zuna, Jan
    Castor, Anders
    Johansson, Bertil
    Paulsson, Kajsa
    GENES CHROMOSOMES & CANCER, 2024, 63 (05)
  • [40] Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
    Greinix, Hildegard T.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 36 - 42